FindTrial
Sign In

To study clinical profile and outcome of lung cancer patients.

TO study clinicopathological profile and outcome of lung cancer patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2018/03/012791
Enrollment
300
Registered
2018-03-23
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- LUNG CANCER

Interventions

Intervention1: Chemotherapy: Chemotherapy was given according to the standard of care.

Sponsors

SAFDARJUNG HOSPITAL AND VMMCNEW DELHI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All histological proven patients of lung cancer

Exclusion criteria

Exclusion criteria: Patient not willing to enter the study and Patients with metastatic lung secondaries.

Design outcomes

Primary

MeasureTime frame
Overall survival,Progression Free SurvivalTimepoint: At the time of death.—

Secondary

MeasureTime frame
Response rate, Quality of life assessmentTimepoint: After chemotherapy—

Countries

India

Contacts

Public ContactDR JC SURI

VARDHMAN MAHAVIR MEDICAL COLLEGE AND SAFDARJUNG HOSPITAL

shibdas1@yahoo.co.in9968303547

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026